Literature DB >> 3978556

Testicular tumors in the Netherlands.

A Zwaveling, R Soebhag.   

Abstract

The data of 764 patients, registered with the Netherlands Committee for Testicular Tumors during the 1971-1978 period, were analyzed. To a large degree the results were in agreement with those in the literature. Chest x-rays and bipedal lymphangiograms were the most useful investigations for detection of metastases, with supplementation by lung planigraphy where indicated. Local invasion of extratesticular tissue by tumor had no relationship to prognosis. The survival figures were comparable to those of the better series in the literature. There was essentially no difference between the behavior and treatment of combined tumors and malignant teratomas, so these may be viewed as a single entity. Because recurrences occurred after 2 years in 21% of seminoma patients, and in 4% of nonseminoma patients, a minimum follow-up period of 5 years is desirable.

Entities:  

Mesh:

Year:  1985        PMID: 3978556     DOI: 10.1002/1097-0142(19850401)55:7<1612::aid-cncr2820550734>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.

Authors:  M Schaapveld; A W van den Belt-Dusebout; J A Gietema; R de Wit; S Horenblas; J A Witjes; H J Hoekstra; L A L M Kiemeney; W J Louwman; G M Ouwens; B M P Aleman; F E van Leeuwen
Journal:  Br J Cancer       Date:  2012-10-11       Impact factor: 7.640

2.  The timing of introduction of pharmaceutical innovations in seven European countries.

Authors:  Ragnar Westerling; Marcus Westin; Martin McKee; Rasmus Hoffmann; Iris Plug; Grégoire Rey; Eric Jougla; Katrin Lang; Kersti Pärna; José L Alfonso; Johan P Mackenbach
Journal:  J Eval Clin Pract       Date:  2014-04-22       Impact factor: 2.431

3.  Risk of diabetes after para-aortic radiation for testicular cancer.

Authors:  Harmke J Groot; Jourik A Gietema; Berthe M P Aleman; Luca Incrocci; Ronald de Wit; J Alfred Witjes; Gerard Groenewegen; Peter de Brouwer; Otto W M Meijer; Maarten C C M Hulshof; Hetty A van den Berg; Tineke J Smilde; Ben G L Vanneste; Maureen J Aarts; Alphonsus C M van den Bergh; J Martijn Kerst; Alexandra W van den Belt-Dusebout; Sjoukje Lubberts; Katarzina Jóźwiak; Simon Horenblas; Flora E van Leeuwen; Michael Schaapveld
Journal:  Br J Cancer       Date:  2018-10-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.